BACKGROUND: The Medical Research Council of Canada (MRCC) is the major Canadian agency responsible for funding biomedical health research in this country. Disease-specific funding by the United States National Institutes of Health (NIH) has been studied and is not independent of burden-of-disease parameters. We tested the association between disease-specific MRCC funding, disease-specific NIH funding and various burden-of-disease parameters. METHOD: Information on 1994/99 MRCC funding was obtained from the MRCC database for 29 diseases. NIH funding and burden-of-disease counterparts for the year 1996 were gleaned from a recent publication. The association between data series was measured by correlation coefficients. RESULTS: Disease-specific incidence, mortality and years-of-life lost did not correlate significantly with 1994/99 disease-specific MRCC funding but prevalence (r = 0.54, p = 0.005) and disability-adjusted life-years did (r = 0.48, p = 0.009). A correlation coefficient of 0.50 (p = 0.006) was calculated between 1996 NIH funding and 1996/97 MRCC funding. Two disease categories, cirrhosis and alcohol abuse, received a greater percentage of funds from the NIH than from the MRCC. Two other disease categories, epilepsy and perinatal disease, received a greater percentage of funds from the MRCC than from the NIH. CONCLUSIONS: Disease-specific MRCC grants in the past 5 years correlated with 2 of the usual burden-of-disease parameters: disability-adjusted life-years and disease prevalence. A statistically-significant correlation was observed between disease-specific grants awarded by the MRCC and the NIH.
BACKGROUND: The Medical Research Council of Canada (MRCC) is the major Canadian agency responsible for funding biomedical health research in this country. Disease-specific funding by the United States National Institutes of Health (NIH) has been studied and is not independent of burden-of-disease parameters. We tested the association between disease-specific MRCC funding, disease-specific NIH funding and various burden-of-disease parameters. METHOD: Information on 1994/99 MRCC funding was obtained from the MRCC database for 29 diseases. NIH funding and burden-of-disease counterparts for the year 1996 were gleaned from a recent publication. The association between data series was measured by correlation coefficients. RESULTS: Disease-specific incidence, mortality and years-of-life lost did not correlate significantly with 1994/99 disease-specific MRCC funding but prevalence (r = 0.54, p = 0.005) and disability-adjusted life-years did (r = 0.48, p = 0.009). A correlation coefficient of 0.50 (p = 0.006) was calculated between 1996 NIH funding and 1996/97 MRCC funding. Two disease categories, cirrhosis and alcohol abuse, received a greater percentage of funds from the NIH than from the MRCC. Two other disease categories, epilepsy and perinatal disease, received a greater percentage of funds from the MRCC than from the NIH. CONCLUSIONS: Disease-specific MRCC grants in the past 5 years correlated with 2 of the usual burden-of-disease parameters: disability-adjusted life-years and disease prevalence. A statistically-significant correlation was observed between disease-specific grants awarded by the MRCC and the NIH.
Authors: Manuel Krone; Vera Dufner; Martin Wagner; Götz Gelbrich; Georg Ertl; Peter U Heuschmann Journal: Clin Res Cardiol Date: 2018-04-13 Impact factor: 5.460
Authors: Sze Lin Yoong; Alix Hall; Christopher M Williams; Eliza Skelton; Christopher Oldmeadow; John Wiggers; Chante Karimkhani; Lindsay N Boyers; Robert P Dellavalle; John Hilton; Luke Wolfenden Journal: J Epidemiol Community Health Date: 2015-04-17 Impact factor: 3.710
Authors: Eduardo Martínez-Martínez; María Luisa Zaragoza; Elmer Solano; Brenda Figueroa; Patricia Zúñiga; Juan P Laclette Journal: PLoS One Date: 2012-12-10 Impact factor: 3.240